Latest return on equity
Amylyx Pharmaceuticals Return on equity
Amylyx Pharmaceuticals (AMLX) return on equity with its verified observation da…
Direct answer
Amylyx Pharmaceuticals's return on equity is -74.73%.
The verified market snapshot reports -74.73%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked August 25, 2026.
Get free Amylyx Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -74.73%
Explore related company data
View Amylyx Pharmaceuticals's market capitalizationView Amylyx Pharmaceuticals's price-to-book ratioView Amylyx Pharmaceuticals's 52-week price rangeView Amylyx Pharmaceuticals's profit marginView Amylyx Pharmaceuticals's debt-to-equity ratioView all Amylyx Pharmaceuticals key metricsReturn to Amylyx Pharmaceuticals profile